These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16228017)

  • 1. Librarians, crystal structures and drug design.
    Allen FH; Taylor R
    Chem Commun (Camb); 2005 Nov; (41):5135-40. PubMed ID: 16228017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research applications of the Cambridge Structural Database (CSD).
    Allen FH; Taylor R
    Chem Soc Rev; 2004 Oct; 33(8):463-75. PubMed ID: 15480471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remarkable features in lattice-parameter ratios of crystals. II. Monoclinic and triclinic crystals.
    de Gelder R; Janner A
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):296-303. PubMed ID: 15914894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge-based model of hydrogen-bonding propensity in organic crystals.
    Galek PT; Fábián L; Motherwell WD; Allen FH; Feeder N
    Acta Crystallogr B; 2007 Oct; 63(Pt 5):768-82. PubMed ID: 17873446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis.
    Brameld KA; Kuhn B; Reuter DC; Stahl M
    J Chem Inf Model; 2008 Jan; 48(1):1-24. PubMed ID: 18183967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering H-bonding rules in crystals with inductive logic programming.
    Ando HY; Dehaspe L; Luyten W; Van Craenenbroeck E; Vandecasteele H; Van Meervelt L
    Mol Pharm; 2006; 3(6):665-74. PubMed ID: 17140254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent hydrogen bonding in polymorphic crystal structures.
    Galek PT; Fábián L; Allen FH
    Acta Crystallogr B; 2009 Feb; 65(Pt 1):68-85. PubMed ID: 19155561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remarkable features in lattice-parameter ratios of crystals. I. Orthorhombic, tetragonal and hexagonal crystals.
    de Gelder R; Janner A
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):287-95. PubMed ID: 15914893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchy of supramolecular synthons: persistent hydroxyl...pyridine hydrogen bonds in cocrystals that contain a cyano acceptor.
    Bis JA; Vishweshwar P; Weyna D; Zaworotko MJ
    Mol Pharm; 2007; 4(3):401-16. PubMed ID: 17500564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relational database driven two-dimensional chemical graph analysis.
    Wilkens SJ
    Chem Biol Drug Des; 2006 Sep; 68(3):135-8. PubMed ID: 17062010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GI Epidemiology: databases for epidemiological studies.
    Davila JA; El-Serag HB
    Aliment Pharmacol Ther; 2007 Jan; 25(2):169-76. PubMed ID: 17229241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cambridge Structural Database in retrospect and prospect.
    Groom CR; Allen FH
    Angew Chem Int Ed Engl; 2014 Jan; 53(3):662-71. PubMed ID: 24382699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank.
    Kellenberger E; Muller P; Schalon C; Bret G; Foata N; Rognan D
    J Chem Inf Model; 2006; 46(2):717-27. PubMed ID: 16563002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés".
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):553-62. PubMed ID: 16562983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides.
    Babu NJ; Reddy LS; Nangia A
    Mol Pharm; 2007; 4(3):417-34. PubMed ID: 17497888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Space group P1: an update.
    Marsh RE
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):359. PubMed ID: 15914902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.